Co-administration of vancomycin and piperacillin-tazobactam is associated with increased renal dysfunction in adult and pediatric burn patients

Burn patients are prone to infections which often necessitate broad antibiotic coverage. Vancomycin is a common antibiotic after burn injury and is administered alone (V), or in combination with imipenem-cilastin (V/IC) or piperacillin-tazobactam (V/PT). Sparse reports indicate that the combination...

Full description

Saved in:
Bibliographic Details
Main Author: Hundeshagen, Gabriel (Author)
Format: Article (Journal)
Language:English
Published: 20 December 2017
In: Critical care
Year: 2017, Volume: 21
ISSN:1466-609X
DOI:10.1186/s13054-017-1899-3
Online Access:Verlag, kostenfrei, Volltext: http://dx.doi.org/10.1186/s13054-017-1899-3
Verlag, kostenfrei, Volltext: https://doi.org/10.1186/s13054-017-1899-3
Get full text
Author Notes:Gabriel Hundeshagen, David N. Herndon, Karel D. Capek, Ludwik K. Branski, Charles D. Voigt, Elizabeth A. Killion, Janos Cambiaso-Daniel, Michaela Sljivich, Andrew De Crescenzo, Ronald P. Mlcak, Michael P. Kinsky, Celeste C. Finnerty, William B. Norbury
Description
Summary:Burn patients are prone to infections which often necessitate broad antibiotic coverage. Vancomycin is a common antibiotic after burn injury and is administered alone (V), or in combination with imipenem-cilastin (V/IC) or piperacillin-tazobactam (V/PT). Sparse reports indicate that the combination V/PT is associated with increased renal dysfunction. The purpose of this study was to evaluate the short-term impact of the three antibiotic administration types on renal dysfunction.
Item Description:Gesehen am 04.10.2018
Physical Description:Online Resource
ISSN:1466-609X
DOI:10.1186/s13054-017-1899-3